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Objectives: Partial nephrectomy is the standard treatment for the small renal mass. C index, one of the
nephrometric systems, was found to be associated with short-term renal functional outcome after
laparoscopic partial nephrectomy. We conducted this study to externally validate the application of C
index as a prognostic factor of long-term renal functional outcome after open partial nephrectomy (OPN)
for small renal mass.
Materials and Methods: The medical records of 65 consecutive patients undergoing OPN from June 2004
to November 2011 were reviewed. C index was calculated on preoperative computed tomography or
magnetic resonance images. The estimated glomerular ﬁltration rate was calculated using the modiﬁ-
cation of diet in renal disease 2 equation. Short-term and long-term renal functional outcomes were
assessed by the nadir estimated glomerular ﬁltration rate within postoperative 1 week and 1 to 2 years.
The correlation between C index, perioperative parameters, and renal functional outcomes were
examined.
Results: The median C index in our cohort was 2.2. C index was associated with operative time, cold
ischemia time, estimated blood loss, and length of hospital stay (p ¼ 0.03, 0.001, 0.001, and 0.02,
respectively). On logistic linear regression analysis, C index (p ¼ 0.01) and operative time (p < 0.001)
were associated with the short-term percent decrease of the estimated glomerular ﬁltration rate,
whereas C index (p ¼ 0.03) was associated with the long-term percent decrease of the estimated
glomerular ﬁltration rate. Under the criteria of C index  2.5, the sensitivity/speciﬁcity were 83.3%/53.8%
and 80%/52% in predicting chronic kidney disease stage 3 or greater in the short-term and long-term
follow-up, respectively. Moreover, the mean long-term percent decrease of the estimated glomerular
ﬁltration rate in patients with C index  2.5 was much higher compared with that of patients with C
index > 2.5 (18.1% vs. 0%, p ¼ 0.001).
Conclusion: C index could serve as an indicator for both short-term and long-term renal functional
decrease after OPN. For patients with C index  2.5, a comprehensive analysis of vascular anatomy and
planning for dissection are crucial in preoperative assessment, and every effort should be exerted to
minimize renal parenchymal damage during surgery.
Copyright  2013, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
The incidence of small renal mass (SRM), generally deﬁned as an
enhancing renal mass  4 cm, has increased substantially over thehina Medical University Hos-
Number 2, Yu-Der Road, Tai-
u).
ciation. Published by Elsevier Taiwpast few decades owing to the widespread use of modern imaging
procedures.1 Approximately 80% of SRM is malignant, but there is
no speciﬁc imaging features to identify the mass as malignant or
benign tumor.1 According to the American Urological Association
guidelines in 2009 and the European Association of Urology
guidelines in 2010, complete surgical excision by open partial ne-
phrectomy (OPN) is the standard treatment for SRM, whereas
laparoscopic partial nephrectomy (LPN) is offered as an alternative
in experienced centers and robot-assisted partial nephrectomyan LLC. Open access under CC BY-NC-ND license.
Table 1
Patient demographics and functional outcomes.
Number of patients 51
Gender (female/male) 20:31
Mean age (range) (y) 57.9 (25e83)
Median tumor diameter (range) (cm) 3.1 (1.5e4)
Median C index (range) 2.2 (1e8)
Mean operative time (range) (min) 258 (155e540)
Mean cold ischemia time (range) (min) 39.5 (17e71)
Mean estimated blood loss (range) (mL) 239 (50e1600)
Complication (n) 9
Mean length of hospital stay (d) 10.6 (7e44)
Mean preoperative eGFR (mL/min/1.73 m2) 82.7 (17e137)
Mean postoperative eGFR (mL/min/1.73 m2)
Within 1 wk 71.4 (14e132)
Within 1e2 y 76.9 (24e115)
Table 3
Correlation between C index and perioperative parameters.
Spearman’s rho p
Operative time 0.407 0.03
Cold ischemia time 0.448 0.001
Estimated blood loss 0.457 0.001
Complication 0.145 0.31
Length of hospital stay 0.338 0.02
Table 4
Analysis for short-term functional outcome.
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nephrometric system, C index, to evaluate the surgical complexity
during LPN. C index is also associated with renal functional
outcome within 1 week after LPN.5 We performed this study to
externally validate the application of C index as a prognostic factor
of long-term renal functional outcome after OPN for SRM.
2. Materials and methods
We retrospectively reviewed the medical records of 65 consec-
utive patients with SRM who underwent OPN by six surgeons from
June 2004 to November 2011 in China Medical University Hospital.
Inclusion criteria were unilateral, localized, sporadic, and solid
renal mass with enhancement on computed tomography or mag-
netic resonance images. OPN was performed due to suspicion of
malignancy. As for surgical techniques, patients received periop-
erative hydration, and mannitol was administered just before renal
artery clamping. The renal artery was occluded by an atraumatic
bulldog clamp, and then renal surface cooling was achieved with
sterile ice slush. After the cold ischemic environment was set, the
renal mass was resected with a 5-mm margin of normal tissue.
Patients’ age, gender, comorbidity of diabetes or hypertension, and
perioperative parametersdincluding operative time, cold ischemia
time, estimated blood loss, complications, and length of hospital
staydwere recorded. After the operation, the patients were fol-
lowed up at our clinic for imaging studies and renal function. The
estimated glomerular ﬁltration rate (eGFR) was assessed by the
modiﬁcation of diet in renal disease 2 (MDRD 2) equation [eGFR
(mL/min/1.73 m2) ¼ 175  Cre(e1.154)  age(e0.203) (0.742 if fe-
male)], and the stage of chronic kidney disease (CKD) was deﬁned
according to the deﬁnition provided by the National Kidney
Foundation.6,7 Short-term and long-term renal functional out-
comes were deﬁned as the nadir eGFR within 7 days of operation
and between postoperative 1 and 2 years, respectively. C index,
deﬁned as the ratio of the distance between the tumor and kidney
center to tumor radius, was calculated according to computed to-
mography or magnetic resonance images. We conducted SpearmanTable 2
Distribution of preoperative and postoperative CKD stages.
Overall no. (%)
Preoperative Postoperative
1 wk
Postoperative
1e2 y
Stage 1 (eGFR  90) 21 (41.2) 6 (11.8) 8 (26.7)
Stage 2 (eGFR 60e89) 22 (43.1) 34 (66.7) 17 (56.7)
Stage 3 (eGFR 30e59) 7 (13.7) 9 (17.6) 4 (13.3)
Stage 4 (eGFR 15e29) 1 (2.0) 1 (2.0) 1 (3.3)
Stage 5 (eGFR < 15) 0 1 (2.0) 0correlations to assess the relationship between C index and peri-
operative parameters. Logistic linear regression analysis was done
to evaluate the relevant parameters for short-term and long-term
renal function. A receiver operating characteristic curve was used
to determine the cutoff value of C index in predicting CKD stage 3 or
greater. Statistical analysis was performed using Statistical Product
and Service Solution (SPSS), version 17.0, and a p value < 0.05 was
considered statistically signiﬁcant. The protocols of this study were
approved by the Ethics Committee of China Medical University
Hospital.
3. Results
Of the 65 patients evaluated, 13 were lacking in preoperative
digital images or complete recording of perioperative data. One
patient with bilateral SRM was also excluded. Table 1 lists the pa-
tient demographics and functional outcomes. The median C index
was 2.2 (range, 1e8). Four patients in our cohort had major intra-
operative bleeding and required blood transfusion. Five patients
had postoperative complications, including delayed bleeding, uri-
nary tract infection, urinary leakage, perirenal abscess formation,
and pulmonary edema due to ﬂuid overload, respectively. The
mean preoperative eGFR was 82.7 mL/min/1.73 m2 (range, 17e137),
and the mean percent change in eGFR was 13.7% within post-
operative 1 week and 7% within postoperative 1e2 years. Distri-
bution rates of perioperative CKD stages are shown in Table 2.
Table 3 shows the correlations between C index and perioper-
ative parameters. We found that C index was correlated with
operative time (p¼ 0.03), cold ischemia time (p¼ 0.001), estimated
blood loss (p ¼ 0.001), and length of hospital stay (p ¼ 0.02),
whereas C index had no impact on the complication rate (p ¼ 0.31).
As for renal functional outcome after OPN, we found that
gender, age, C index, operative time, and preoperative eGFR were
correlated with short-term nadir eGFR, whereas only C index and
operative time were correlated with percent decrease of eGFR
(p ¼ 0.01 and p < 0.001, respectively; Table 4). Long-term renal
function proﬁles were available in 30 patients. We found that C
index and preoperative eGFR were correlated with long-term nadir
eGFR, whereas only C index was correlated with long-term percentNadir eGFR Percentage decrease of eGFR
Beta T p Beta t p
Gender 0.204 2.86 0.01 0.107 0.926 0.36
Age 0.173 2.457 0.02 0.085 0.768 0.45
Diabetes 0.005 0.08 0.94 0.071 0.64 0.53
Hypertension 0.13 1.774 0.08 0.177 1.623 0.11
Tumor size 0.025 0.285 0.78 0.121 0.85 0.4
C index 0.167 2.453 0.02 0.299 2.583 0.01
Operative time 0.259 3.57 0.001 0.494 4.263 <0.001
Cold ischemia time 0.52 0.722 0.48 0.035 0.28 0.78
Estimated blood loss 0.061 0.858 0.4 0.134 1.147 0.26
Preoperative GFR 0.568 7.958 <0.001 0.216 1.981 0.05
Beta ¼ standardized coefﬁcient.
Table 5
Analysis for long-term functional outcome.
Nadir eGFR Percentage decrease of eGFR
Beta t p Beta t p
Gender 0.014 0.15 0.88 0.022 0.124 0.9
Age 0.149 1.683 0.1 0.309 1.822 0.08
Diabetes 0.032 0.361 0.72 0.085 0.47 0.64
Hypertension 0.036 0.38 0.71 0.118 0.618 0.54
Tumor size 0.019 0.159 0.88 0.067 0.278 0.78
C index 0.253 2.945 0.01 0.391 2.245 0.03
Operative time 0.091 0.995 0.35 0.235 1.259 0.22
Cold ischemia time 0.003 0.023 0.98 0.003 0.012 0.99
Estimated blood loss 0.061 0.658 0.52 0.164 0.902 0.38
Preoperative GFR 0.884 10.279 <0.001 0.158 0.899 0.38
Beta ¼ standardized coefﬁcient.
Table 6
Long-term percent GFR decrease stratiﬁed by C index 2.5 cutoffs.
No. C index  2.5 (%) No. C index > 2.5 (%) RR
Overall 16 14
Percentage GFR decrease
>30% 2 (12.5) 0
>20% 3 (18.8) 0
>10% 12 (75) 2 (14.3) 5.2
GFR ¼ glomerular ﬁltration rate; RR ¼ relative risk.
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including gender, age, diabetes, hypertension, preoperative GFR,
and tumor size as well as surgical factors including operative time,
cold ischemia time, and estimated blood loss were not correlated
with long-term percent decrease of eGFR (Table 5). In the receiver
operating characteristic curve for assessing the predictiveness of C
index toward CKD stage 3 or greater, we found that, under the
criteria of C index 2.5, the sensitivity/speciﬁcity were 83.3%/53.8%
and 80%/52% in the short-term and long-term functional outcomes,
respectively (Fig. 1). In addition, the long-term mean percent
decrease of eGFR in the group of C index  2.5 was much higher
than that in the group of C index> 2.5 (18.1% vs. 0%, p¼ 0.001), and
C index  2.5 carried a 5.2-fold risk of decrease of eGFR of more
than 10% (Table 6).4. Discussion
In order to standardize the description of the anatomical fea-
tures of a renal tumor, three nephrometric systems have been
proposed: R.E.N.A.L., PADUA, and C index systems.4,8,9 The R.E.N.A.L.
system is an itemized readout of tumor features including tumor
radius, exophytic extent, nearness to the renal sinus, anterior/
posterior location, and location relative to the polar lines. The
PADUA system, compared with the R.E.N.A.L. system, further scores
the relationship to the sinus fat and collecting system as indepen-
dent factors. However, the PADUA output is a sum score and thus
relatively weak in conveying anatomic information. C index is a0 20 40 60 80 100
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Fig. 1. ROC for the predictiveness of C index toward CKD stage 3 or greater. (A) For short-ter
0.64. AUC ¼ area under the curve; CKD ¼ chronic kidney disease; ROC ¼ receiver operatincomprehensive score calculated by tumor depth and size. Because C
index is based solely on measured distances, it is less prone to be
affected by the observer’s subjectivity.10 Initially developed as a
surrogate of technical complexity during LPN, C index is also
associated with short-term functional outcome after LPN.5 To our
knowledge, there is no report in the literature discussing the long-
term inﬂuence of C index on renal function after PN. Thus, we
conducted this study to provide external validation for C index.
Canter et al11 found that in patients presenting with solid renal
tumors, although 88% had normal serum creatinine, 22% of them
had CKD stage 3 or greater. In Taiwan, the prevalence of CKD is
among the highest in the world, but the awareness rate is low.12 In
our cohort, 15.7% of patients with SRM undergoing PN had CKD
stage 3 or greater. Because CKD stage 3 or greater carries a higher
risk of cardiovascular events, days of hospitalization, and death, the
issue of renal function preservation during PN cannot be over-
emphasized.13,14 Our data revealed a decline of renal function due
to an ischemic insult in postoperative 1 week and partial recovery
in postoperative 1 to 2 years (Table 3). Lane et al15 also reported that
renal function declined immediately after PN and returned to a new
steady state generally within 3 weeks. At a mean follow-up of 1.5
years, preoperative GFR, age, gender, absent or poorly functioning
contralateral kidney, and warm ischemia time were signiﬁcant
predictors of ultimate renal function.15 Jeldres et al16 reported that
preoperative renal function, perioperative blood loss, and ischemia
time were independent predictors of >25% reduction in GFR after
PN. Thompson et al17 found that longer warm ischemia time was
associated with acute renal failure (odds ratio ¼ 1.05 for each 1-
minute increase) and new-onset CKD stage 4 for patients with
solitary kidney undergoing PN. However, if renal parenchymal
preservation is incorporated into the analysis, only preoperative
GFR and percent functional volume preservation were reported to
be correlated with long-term renal function after PN.18 In a large0 20 40 60 80 100
0
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B
m functional outcome, AUC was 0.638. (B) For long-term functional outcome, AUC was
g characteristic curve.
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renchyma preserved (p < 0.00001) and preoperative GFR
(p < 0.00001) were the strongest predictors of renal function after
OPN, whereas age (p ¼ 0.0008) and tumor size (p ¼ 0.0003) play
less signiﬁcant roles.
In the present study, C index (p ¼ 0.01) and operative time
(p < 0.001) were correlated with short-term percent decrease of
eGFR, whereas C index (p ¼ 0.03) was correlated with long-term
percent decrease of eGFR. A lower C index implies that the larger
the tumor size and/or the shorter the distance between the tumor
and the kidney center, the greater the renal parenchymal reduction
would be expected during tumor excision. In fact, the width of the
resection margin is irrelevant to disease progression.20,21 However,
a large resection margin has the potential risk of violating the
collecting system, causing injury to the hilar vessels, or even hin-
dering the ability of the surgeons to perform PN. Thus, the surgical
margin should be kept as minimal as possible to preserve normal
renal parenchyma, and intraoperative frozen section analysis may
be used as necessary.22
The percentage of GFR decrease after PN was reported to range
from 5% to 8.8% upon follow-up of 1 to 1.5 years.15,23,24 In our series,
a 7% GFR decrease was noted within postoperative 1 to 2 years. C
index <2.5 has been reported to correlate with a 2.2-fold increased
risk of a >30% GFR decrease within 1 week after LPN.5 In our series,
we also found that the long-term percent decrease of GFR was
much higher in C index  2.5 compared with C index > 2.5 (18.1%
vs. 0%, p ¼ 0.001), and C index  2.5 carried a 5.2-fold risk of
decrease in eGFR of more than 10%. However, our case numbers
were too small to show the relative risk of decrease of eGFR of more
than 20% or 30%. Nevertheless, C index 2.5 showed fair sensitivity
(80%) and speciﬁcity (52%) in predicting long-term CKD stage 3 or
greater. Therefore, patients with C index  2.5 should be regarded
as having a high risk of signiﬁcant renal functional reduction. For
these high-risk patients, OPN, instead of LPN, may be more suitable
in consideration of shortening the ischemia time and minimizing
the complication rate.2,3 Moreover, a comprehensive analysis of
vascular anatomy and planning for dissection are very important in
order to preserve the normal parenchyma as much as possible.
Finally, early lifestyle modiﬁcation, adjustment of medication, or
referral to a nephrologist may be warranted.
It is rather complex to predict the long-term renal function after
PN, as it may be confounded by patients’ medical comorbidities.
However, hypertension, diabetes, body mass index, smoking, and
Charlson index were reported not to be correlated with long-term
renal functional outcome after PN.15,25,26 In our series, hypertension
and diabetes were not associated with long-term renal functional
outcome either. By contrast, although preoperative GFR was
correlated with ultimate GFR, it does not play a signiﬁcant role in
determining the percent reduction of GFR.18,19,26 In fact, the extent
of renal parenchymal preservation remains themost important and
modiﬁable factor in determining long-term renal function after
PN.19,26 C index, calculated by the tumor size and depth, may help
us to access how much renal parenchyma could be preserved
during preoperative planning; however, further research is needed
to validate this concept.
The mean cold ischemia time in our study was 39.5 minutes. In
line with previous series, cold ischemia time was not associated
with long-term renal function impairment.27,28 Although cold
ischemia time up to 2 hours could be tolerated by the kidney,
Thompson et al recommended that it should be limited within 35
minutes if technically feasible to decrease the risk of acute renal
failure and urinary leakage.29,30
There are several limitations in our study. This is a retrospective
and single-institution study with small case numbers. We included
only patients with renal tumors 4 cmwhowere undergoing OPN.Future larger-scale studies conducting comparisons between LPN
and OPN may be needed to validate these results. Moreover, the
most accurate way to determine renal function is by using renal
scintigraphy with technetium-99 m-mercaptoacetyltriglycine.31 In
consideration of cost-effectiveness, we used the MDRD 2 equation,
which was also recommended for the assessment of renal function
after nephrectomy.32
5. Conclusion
C index could serve as an indicator for both short-term and long-
term renal functional decrease after OPN. For patients with C
index  2.5, a comprehensive analysis of vascular anatomy and
planning for dissection are crucial in preoperative assessment, and
every effort should be exerted to minimize renal parenchymal
damage during surgery.
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